Product: Irbesartan Bulk Active Pharmaceutical Ingredient.
Reason for recall: CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.
Recall initiated: 20181024
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated